ArticleCells2025

The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL.

Joaquín Marco-Brualla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.